Open Access
| Numéro |
Med Sci (Paris)
Volume 37, Numéro 8-9, Août–Septembre 2021
|
|
|---|---|---|
| Page(s) | 712 - 715 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/2021099 | |
| Publié en ligne | 7 septembre 2021 | |
- Carelli V Carbonelli M de Coo IF et al. International consensus statement on the clinical and therapeutic management of Leber hereditary optic neuropathy. J Neuroophthalmol 2017 ; 37 : 371–381. [CrossRef] [PubMed] [Google Scholar]
- Newman NJ, Carelli V, Taiel M, Yu-Wai-Man P. Visual outcomes in Leber hereditary optic neuropathy patients with the m.11778G>A (MTND4) mitochondrial DNA mutation. J Neuroophthalmol 2020; 40 : 547–57. [CrossRef] [PubMed] [Google Scholar]
- Catarino CB, von Livonius B, Priglinger C, et al. Real-world clinical experience with Idebenone in the treatment of Leber hereditary optic neuropathy. J Neuroophthalmol 2020; 40 : 558–65. [CrossRef] [PubMed] [Google Scholar]
- Cwerman-Thibault H Augustin S Lechauve C et al. Nuclear expression of mitochondrial ND4 leads to the protein assembling in complex I and prevents optic atrophy and visual loss. Mol Ther Methods Clin Dev 2015 ; 2 : 15003. [CrossRef] [PubMed] [Google Scholar]
- Vignal C Uretsky S Fitoussi S et al. Safety of rAAV2/2-ND4 gene therapy for Leber hereditary optic neuropathy. Ophthalmology 2018 ; 125 : 945–947. [CrossRef] [PubMed] [Google Scholar]
- Vignal-Clermont C, Girmens JF, Audo I, et al. Safety of intravitreal gene therapy for treatment of subjects with Leber hereditary optic neuropathy due to mutations in the mitochondrial ND4 gene: the Reveal study. BioDrugs 2021; 35 : 201–14. [CrossRef] [PubMed] [Google Scholar]
- Yu-Wai-Man P, Newman NJ, Carelli V, et al. Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy. Sci Transl Med 2020; 12 : eaaz7423. [CrossRef] [PubMed] [Google Scholar]
- Newman NJ, Yu-Wai-Man P, Carelli V, el al. Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset. Ophthalmology 2021; S0161–6420 : 31187–8. [PubMed] [Google Scholar]
- Yu-Wai-Man P, Newman NJ, Carelli V, et al. Natural history of patients with Leber hereditary optic neuropathy: results from the Reality study. Eye 2021; doi: 10.1038/s41433-021-01535-9. [Google Scholar]
- Newman NJ, Yu-Wai-Man P, Carelli V. Intravitreal gene therapy versus natural history in patients with Leber hereditary optic neuropathy carrying the m.11778G>A ND4 mutation: systematic review and indirect comparison. Front Neurosci 2021; doi: 10.3389/fneur.2021.662838. [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.